Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 31, 2007. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons regarding the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
No material changes to financial performance or operations are reported. The filing details a specific transaction on January 29, 2007, where Abacus (GSK) Trustees Limited transferred 5,358 Ordinary Shares from the GlaxoSmithKline Employee Trust to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are interested in the shares held in the GSK Trust in the same capacity as other employees.
Investor Verification Points
- Verify the total number of shares transferred (5,358) and the date of the transaction (January 29, 2007).
- Confirm the involvement of the GlaxoSmithKline Employee Trust and the SmithKline Beecham Employee Share Option Plan 1991.
- Note that this filing does not contain financial results; investors should refer to Form 20-F for financial data.